Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Phibro Animal Health stock have an average target of 21, with a low estimate of 15 and a high estimate of 25. The average target predicts a decrease of -2.46% from the current stock price of 21.53.

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$15	$21	$22	$25
Change	-30.33%	-2.46%	+2.18%	+16.12%

* Price targets were last updated on Feb 10, 2025.

Analyst Ratings

The average analyst rating for Phibro Animal Health stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	1	2	2	2	2
Sell	2	2	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	4	3	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Balaji Prasad Barclays	Barclays	Sell Maintains $20 → $22	Sell	Maintains	$20 → $22	+2.18%	Feb 10, 2025
Erin Wright Morgan Stanley	Morgan Stanley	Hold Maintains $20 → $25	Hold	Maintains	$20 → $25	+16.12%	Dec 17, 2024
Balaji Prasad Barclays	Barclays	Sell Maintains $13 → $20	Sell	Maintains	$13 → $20	-7.11%	Nov 12, 2024
Ekaterina Knyazkova JP Morgan	JP Morgan	Hold Initiates $22	Hold	Initiates	$22	+2.18%	Sep 10, 2024
Derik De Bruin B of A Securities	B of A Securities	Sell Maintains $13 → $15	Sell	Maintains	$13 → $15	-30.33%	Aug 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.31B

Increased by 28.33%

from 1.02B

Revenue Next Year

1.44B

Increased by 10.57%

from 1.31B

EPS This Year

1.97

Increased by 3,204.64%

from 0.06

EPS Next Year

2.14

Increased by 8.41%

from 1.97

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	800.35M	833.35M	942.26M	977.89M	1.02B	1.31B	1.44B	1.48B
Revenue Growth	-3.34%	4.12%	13.07%	3.78%	4.07%	28.33%	10.57%	2.29%
EPS	0.83	1.34	1.21	0.81	0.06	1.97	2.14	2.29
EPS Growth	-38.56%	61.57%	-9.70%	-33.47%	-92.59%	3,204.64%	8.41%	7.08%
Forward PE	-	-	-	-	-	10.92	10.08	9.41
No. Analysts	-	-	-	-	-	7	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1.4B	1.6B	1.6B
Avg	1.3B	1.4B	1.5B
Low	1.3B	1.3B	1.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	33.3%	19.0%	10.5%
Avg	28.3%	10.6%	2.3%
Low	22.8%	-1.1%	-7.5%

EPS Forecast

EPS	2025	2026	2027
High	2.09	2.38	2.66
Avg	1.97	2.14	2.29
Low	1.83	1.85	1.96

EPS Growth

EPS Growth	2025	2026	2027
High	3,403.1%	20.9%	24.3%
Avg	3,204.6%	8.4%	7.1%
Low	2,972.4%	-6.0%	-8.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.